Catherine Tangen

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Pedro Barata

Associate Professor of Medicine

University Hospitals Seidman Cancer Center

UNITED STATES

View details

Seth P. Lerner

Baylor College of Medicine

UNITED STATES

View details

Channing Paller

Johns Hopkins University

UNITED STATES

View details

AKASH ROY

Medical University of South Carolina

UNITED STATES

View details

Marian Neuhouser

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Maha Hussain

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Catherine Tangen

Research Interests

Explore related searches

Contact this professor

Articles (8)

Reply to J.A. Garcia et al

Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer

Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma

DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 Trial

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Crisis of the Clinical Trials Staff Attrition After the COVID-19 Pandemic

Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)

Collaborators (6)

Pedro Barata

Seth P. Lerner

Channing Paller

AKASH ROY

Marian Neuhouser

Maha Hussain

Make your next move.